Quest Laboratories Ltd

Quest Laboratories Ltd IPO

Quest Laboratories Ltd IPO Price Range is ₹93 - 97, with a minimum investment of ₹1,16,400 for 1200 shares.

₹1,16,400

/ 1200 shares

Minimum Investment

View Quest Laboratories Ltd IPO details including price range, minimum investment, lot size, financials, and IPO timeline. Get subscription updates, peer comparison, and key insights to help you make an informed decision.

IPO Status

Closed

Price Band

₹93 - 97

Open Date

2024-05-15

Close Date

2024-05-17

IPO Size

₹43.16 Cr

Lot Size

1200 shares

Min Investment

₹1,16,400

Listing Exchange

NSE

Quest Laboratories Ltd IPO Application Timeline

passed
Open Date15 May 2024
passed
Close Date17 May 2024
passed
Allotment Date21 May 2024
passed
Listing Date23 May 2024

Strengths and Risks

Strengths

Strengths

  • Multi-product capability.

  • Revenue from Government institutions.

  • Product Portfolio.

  • Research and Development.

  • Quality assurance.

  • Experienced Promoter and management team.

  • Supply Chain Efficiency.


Risks

Risks

  • The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.

  • Any manufacturing or quality control problems may disrupt its business operations, damage the company reputation for high quality production and expose it to potential litigation or other liabilities, which would negatively impact its business, prospects, cash flows, results of operations and financial condition.

  • The Company is reliant on the demand from the pharmaceutical industry for a significant portion of its revenue. Any downturn in the pharmaceutical industry or an inability to increase or effectively manage its sales could have an adverse impact on the Companys business and results of operations.

  • The products that the company commercialize may not perform as expected which could adversely affect its business, financial condition and results of operations.

  • Any manufacturing or quality control problems may damage its reputation for high quality products and expose the company to litigation or other liabilities, which could adversely affect its financial results.

  • The availability of counterfeit drugs, such as drugs passed off by others as its products, could adversely affect the company goodwill and results of operations.

  • Its business is dependent and will continue to depend on the companys manufacturing facility, and the company is subject to certain risks in its manufacturing process. Any slowdown or shutdown in the company manufacturing operations or strikes, work stoppages or increased wage demands by its employees that could interfere with the company operations could have an adverse effect on its business, financial condition and results of operations.

  • Its existing manufacturing facility are concentrated in a single region i.e., Pithampur, Indore, Madhya Pradesh and the inability to operate and grow its business in this particular region may have an adverse effect on the company business, financial condition, results of operations, cash flows and future business prospects.

  • The company highly depends on its major raw materials on many of the suppliers who help it procure the same. The Company has not entered into long-term agreements with its suppliers for supply of raw materials. In the event the company is unable to procure adequate amounts of raw materials, at competitive prices its business, results of operations and financial condition may be adversely affected.

  • Too much concentration of its Business is from sale to government which may impact the companys Business.

How to Apply for Quest Laboratories Ltd IPO on INDmoney

1

Download the INDmoney app and complete your KYC to open an account.

2

Go to the INDstocks section and tap on IPO, or search for ‘IPO’.

3

Select Quest Laboratories Ltd IPO from the list of live IPOs.

4

View key details like price band, lot size, and dates, then tap ‘Apply Now’.

5

Choose the number of lots and place your order via UPI.

6

Your funds will be blocked until the share allotment is finalized.

About Quest Laboratories Ltd

Quest Laboratories Limited is engaged in the business of manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. These formulations fall under the trademark Quest Laboratories Limited. The company produces a variety of products, comprising ethical drugs, generic drugs, and overthe-counter drugs (OTC). These products are available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. This comprehensive approach allows the Company to address a wide range of medical needs and preferences among patients.

Frequently Asked Questions of Quest Laboratories Ltd IPO

What is the size of the Quest Laboratories Ltd IPO?

The size of the Quest Laboratories Ltd IPO is ₹43.16 Cr.

What is the allotment date of the Quest Laboratories Ltd IPO?

Quest Laboratories Ltd IPO allotment date is May 21, 2024 (tentative).

What are the open and close dates of the Quest Laboratories Ltd IPO?

The Quest Laboratories Ltd IPO will open on May 15, 2024 and close on May 17, 2024

What is the lot size of Quest Laboratories Ltd IPO?

The lot size for the Quest Laboratories Ltd IPO is 1200.

When will my Quest Laboratories Ltd IPO order be placed?

Your Quest Laboratories Ltd IPO order will be placed on May 15, 2024

Can we invest in Quest Laboratories Ltd IPO?

Yes, once Quest Laboratories Ltd IPO opens, you can invest in the shares of the company.

What would be the listing gains on the Quest Laboratories Ltd IPO?

The potential listing gains on the Quest Laboratories Ltd IPO will depend on various market factors and cannot be predicted with certainty.

What is 'pre-apply' for Quest Laboratories Ltd IPO?

'Pre-apply' for Quest Laboratories Ltd IPO indicates your interest in the IPO before it opens for subscription. This ensures quick application when the IPO goes live.